201 related articles for article (PubMed ID: 10319057)
1. Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time.
Faul JL; Leonard CT; Burke CM; Tormey VJ; Poulter LW
Thorax; 1998 Sep; 53(9):753-61. PubMed ID: 10319057
[TBL] [Abstract][Full Text] [Related]
2. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma.
Ward C; Pais M; Bish R; Reid D; Feltis B; Johns D; Walters EH
Thorax; 2002 Apr; 57(4):309-16. PubMed ID: 11923548
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Pavord I; Woodcock A; Parker D; Rice L;
Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478
[TBL] [Abstract][Full Text] [Related]
4. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL
J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141
[TBL] [Abstract][Full Text] [Related]
5. Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma.
Faul JL; Demers EA; Burke CM; Poulter LW
Chest; 2002 May; 121(5):1414-20. PubMed ID: 12006422
[TBL] [Abstract][Full Text] [Related]
6. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
van Rensen EL; Straathof KC; Veselic-Charvat MA; Zwinderman AH; Bel EH; Sterk PJ
Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
[TBL] [Abstract][Full Text] [Related]
7. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study.
Olivieri D; Chetta A; Del Donno M; Bertorelli G; Casalini A; Pesci A; Testi R; Foresi A
Am J Respir Crit Care Med; 1997 Jun; 155(6):1864-71. PubMed ID: 9196087
[TBL] [Abstract][Full Text] [Related]
8. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma.
Bootsma GP; Dekhuijzen PN; Festen J; Mulder PG; van Herwaarden CL
Thorax; 1995 Oct; 50(10):1044-50. PubMed ID: 7491551
[TBL] [Abstract][Full Text] [Related]
9. Effects of fluticasone propionate on methacholine dose-response curves in nonsmoking atopic asthmatics.
Overbeek SE; Rijnbeek PR; Vons C; Mulder PG; Hoogsteden HC; Bogaard JM
Eur Respir J; 1996 Nov; 9(11):2256-62. PubMed ID: 8947069
[TBL] [Abstract][Full Text] [Related]
10. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
O'Sullivan S; Akveld M; Burke CM; Poulter LW
Am J Respir Crit Care Med; 2003 Mar; 167(5):745-50. PubMed ID: 12480610
[TBL] [Abstract][Full Text] [Related]
11. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
[TBL] [Abstract][Full Text] [Related]
12. The effect of fluticasone propionate on functional status and sleep in children with asthma and on the quality of life of their parents.
Mahajan P; Pearlman D; Okamoto L
J Allergy Clin Immunol; 1998 Jul; 102(1):19-23. PubMed ID: 9679843
[TBL] [Abstract][Full Text] [Related]
13. Fluticasone propionate and bronchial hyperresponsiveness in childhood asthma.
Direkwattanachai C; Limkittikul K; Kraisarin C; Sasisakulporn C; Benjaponpitak S
Asian Pac J Allergy Immunol; 1999 Jun; 17(2):63-7. PubMed ID: 10466540
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
15. Effects of varying doses of fluticasone propionate on the physiology and bronchial wall immunopathology in mild-to-moderate asthma.
O'Sullivan S; Cormican L; Murphy M; Poulter LW; Burke CM
Chest; 2002 Dec; 122(6):1966-72. PubMed ID: 12475834
[TBL] [Abstract][Full Text] [Related]
16. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
Hattotuwa KL; Gizycki MJ; Ansari TW; Jeffery PK; Barnes NC
Am J Respir Crit Care Med; 2002 Jun; 165(12):1592-6. PubMed ID: 12070058
[TBL] [Abstract][Full Text] [Related]
17. Influence of different dosage schedules of inhaled fluticasone propionate on peripheral blood cytokine concentrations in childhood asthma.
Visser MJ; Postma DS; Brand PL; Arends LR; Duiverman EJ; Kauffman HF
Clin Exp Allergy; 2002 Oct; 32(10):1497-503. PubMed ID: 12372131
[TBL] [Abstract][Full Text] [Related]
18. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment.
Gershman NH; Wong HH; Liu JT; Fahy JV
Eur Respir J; 2000 Jan; 15(1):11-8. PubMed ID: 10678614
[TBL] [Abstract][Full Text] [Related]
19. Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness.
Verhoeven GT; Hegmans JP; Mulder PG; Bogaard JM; Hoogsteden HC; Prins JB
Thorax; 2002 Aug; 57(8):694-700. PubMed ID: 12149529
[TBL] [Abstract][Full Text] [Related]
20. Sustained reduction in bronchial hyperresponsiveness with inhaled fluticasone propionate within three days in mild asthma: time course after onset and cessation of treatment.
Sovijärvi AR; Haahtela T; Ekroos HJ; Lindqvist A; Saarinen A; Poussa T; Laitinen LA
Thorax; 2003 Jun; 58(6):500-4. PubMed ID: 12775860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
